-       Report 
- February 2023
-  73 Pages 
- United States 
   From       €3115EUR$3,500USD£2,742GBP 
          -       Report 
- December 2022
-  85 Pages 
- Asia Pacific 
   From       €3559EUR$4,000USD£3,133GBP 
          -       Report 
- February 2024
-  175 Pages 
- Global 
   From       €4449EUR$5,000USD£3,917GBP 
          -       Report 
- January 2024
-  426 Pages 
- Global 
   From       €4449EUR$5,000USD£3,917GBP 
            -       Report 
- July 2024
-  100 Pages 
- Global 
   From       €2670EUR$3,000USD£2,350GBP 
      €3337EUR$3,750USD£2,937GBP 
             -       Report 
- July 2024
-  100 Pages 
- Global 
   From       €2670EUR$3,000USD£2,350GBP 
      €3337EUR$3,750USD£2,937GBP 
            -       Report 
- July 2024
-  150 Pages 
- Global 
   From       €2670EUR$3,000USD£2,350GBP 
      €3337EUR$3,750USD£2,937GBP 
          -       Report 
- May 2024
-  200 Pages 
- Global 
   From       €3693EUR$4,150USD£3,251GBP 
          -       Report 
- July 2024
-  115 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- February 2024
-  116 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- February 2024
-  90 Pages 
- Argentina 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- February 2024
-  114 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- February 2024
-  115 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- February 2024
-  115 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- February 2024
-  114 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- April 2023
-  68 Pages 
- Japan 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- April 2023
-  100 Pages 
- North America 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- April 2023
-  81 Pages 
- Spain 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- April 2023
-  71 Pages 
- North America 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- April 2023
-  75 Pages 
- Italy 
   From       €4227EUR$4,750USD£3,721GBP 
       
      The Spinal Cord Stimulator (SCS) is a type of medical device used to treat chronic pain in the lower back, neck, and limbs. It works by sending electrical pulses to the spinal cord, which can help reduce pain signals sent to the brain. SCS is a form of neuromodulation, which is a type of therapy that uses electrical stimulation to modify nerve activity. It is used to treat a variety of conditions, including failed back surgery syndrome, complex regional pain syndrome, and peripheral neuropathy.
SCS    is a minimally invasive procedure, and is typically used when other treatments have failed. It is typically implanted in the lower back, and is connected to a small battery-powered device that is worn externally. The device is programmed to deliver electrical pulses to the spinal cord, which can help reduce pain signals sent to the brain.
The SCS market is a growing segment of the neurology devices market. It is expected to continue to grow as more patients seek out minimally invasive treatments for chronic pain.
Some companies in the SCS market include Medtronic, Boston Scientific, St. Jude Medical, and Nevro. Show Less   Read more